Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug 6;13(1):101.
doi: 10.1186/s13065-019-0625-4. eCollection 2019 Dec.

Pharmacological significance of heterocyclic 1 H-benzimidazole scaffolds: a review

Affiliations
Review

Pharmacological significance of heterocyclic 1 H-benzimidazole scaffolds: a review

Sumit Tahlan et al. BMC Chem. .

Abstract

Heterocyclic compounds are inevitable in a numerous part of life sciences. These molecules perform various noteworthy functions in nature, medication and innovation. Nitrogen-containing heterocycles exceptionally azoles family are the matter of interest in synthesis attributable to the way that they happen pervasively in pharmacologically dynamic natural products, multipurpose arranged useful materials also profoundly powerful pharmaceuticals and agrochemicals. Benzimidazole moiety is the key building block for several heterocyclic scaffolds that play central role in the biologically functioning of essential molecules. They are considered as promising class of bioactive scaffolds encompassing diverse varieties of activities like antiprotozoal, antihelminthic, antimalarial, antiviral, anti-inflammatory, antimicrobial, anti-mycobacterial and antiparasitic. Therefore in the present review we tried to compile the various pharmacological activities of different derivatives of heterocyclic benzimidazole moiety.

Keywords: Anti-inflammatory activity; Anticancer activity; Antimalarial activity; Antimycobacterial activity; Antiprotozoal activity; Antiviral activity; Benzimidazole derivatives.

PubMed Disclaimer

Conflict of interest statement

Competing interestsThe authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Some benzimidazoles containing medicinal preparation
Fig. 2
Fig. 2
Rational designed based on literature survey of benzimidazole derivatives
Fig. 3
Fig. 3
Molecular structures of compounds (1a1b, 2a, 3a3c, 4a, 5a5c, 6a6d, 7a7b, 8a)
Fig. 4
Fig. 4
Molecular structures of compounds (9a9b, 10a10c, 11a11b, 12a12b, 13a, 14a, 15a, 16a16b, 17a17b, 18a)
Fig. 5
Fig. 5
Molecular structures of compounds (19a19d, 20a20b, 21a21c, 22a22b, 23a23d)
Fig. 6
Fig. 6
Molecular structures of compounds (24a, 25a25c, 26a, 27a, 28a, 29a, 30a30b, 31a31g, 32a32b, 33a and 34a)
Fig. 7
Fig. 7
Molecular structures of compounds (35a35e, 36a36d, 37a, 38a38g)
Fig. 8
Fig. 8
Molecular structures of compounds (39a39c, 40a40e, 41a, 42a42b, 43a43c, 44a44b)
Fig. 9
Fig. 9
Molecular structures of compounds (45a45b, 46a, 47a, 48a48b, 49a, 50a50b, 51a51b, 52a, 53a53b, 54a54b)

Similar articles

Cited by

References

    1. Alaqeel SI. Synthetic approaches to benzimidazoles from o-phenylenediamine: a literature review. J Saudi Chem Soc. 2017;21:229–237. doi: 10.1016/j.jscs.2016.08.001. - DOI
    1. Tahlan S, Ramasamy K, Lim SM, Shah SAA, Mani V, Narasimhan B. Design, synthesis and therapeutic potential of 3-(2-(1H-benzo[d]imidazol-2-ylthio) acetamido)-N-(substituted phenyl)benzamide analogues. Chem Cent J. 2019;12(139):1–12. - PMC - PubMed
    1. Tahlan S, Ramasamy K, Lim SM, Shah SAA, Mani V, Narasimhan B. (2-(1H-Benzo[d]imidazol-2-ylthio)acetamido)-N-(substituted phenyl) benzamides: design, synthesis and biological evaluation. BMC Chem. 2019;3(12):1–16. - PMC - PubMed
    1. Alpan AS, Parlar S, Carlino L, Tarikogullari AH, Alptuzun V, Gunes HS. Synthesis biological activity and molecular modeling studies on 1H-benzimidazole derivatives as acetylcholinesterase inhibitors. Bioorg Med Chem. 2013;21:4928–4937. doi: 10.1016/j.bmc.2013.06.065. - DOI - PubMed
    1. Andrzejewskaa M, Yepez-Mulia L, Tapia A, Cedillo-Rivera R, Laudy AE, Starosciak BJ, Kazimierczuk Z. Synthesis and antiprotozoal and antibacterial activities of S-substituted 4,6-dibromo- and 4,6-dichloro-2-mercaptobenzimidazoles. Eur J Pharm Sci. 2004;21:323–329. doi: 10.1016/j.ejps.2003.10.024. - DOI - PubMed

LinkOut - more resources